Top line contracting.
−0.4% YoY versus −4.1% prior. 3y CAGR −2.1%.
−0.4%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Consumer Discretionary · Market Cap: $9.5B
Fundamentals as of 2026-05-02
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
2 of 3 legendary models say HOLD DDS — but Joel Greenblatt disagrees.
What would legendary investors pay for DDS?
These figures are not quotes or opinions from Buffett, Graham, Lynch or the other investors. They are our own estimates, computed by applying the intrinsic-value formulas each investor is known for to this company’s financials.
For educational purposes only. Not a recommendation to buy or sell securities.
Yes — Dillard's, Inc.'s 25.3% ROE ranks above the S&P 500 median, and D/E 0.59 stays within healthy bounds.
Financial story
Yes — Dillard's, Inc.'s 25.3% ROE shows strong capital efficiency, and its 0.59 debt-to-equity stays within healthy bounds.
Bottom line: DDS is flagged as overvalued by 1 of 3 legendary models, with 0 BUY and 2 HOLD, but earns a C sector grade (57/100) in Consumer Discretionary. Whether the premium is justified depends on which lens you trust. Drill into the valuation breakdown and sector ranking for the full picture.
DDS and W differ on P/E, ROE, and revenue growth. See the full DDS vs W compare matrix.
Buffett, Greenblatt, and Munger evaluate DDS against their respective frameworks. Per-model fair value and reasoning are in the valuation tab.
DDS's P/E ratio is 12.8x. 5-year P/E history is in the financials tab.
0 of 3 legendary models say BUY. Full breakdown by investor and signal is in the valuation tab.
DDS's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
DDS is in the Consumer Discretionary sector. Sector ranking and peer comparison are in the sector tab.
How does DDS compare?
−0.4% YoY versus −4.1% prior. 3y CAGR −2.1%.
−0.4%Net margin 8.7% versus 9.0% prior (−0.3pp). Operating 10.5%.
8.7%P/E 14.4x — 51% above the 5y median of 9.6x. Forward 16.4x signals EPS contraction next year.
14.4xSee exactly where DDS ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingDDS sits at #33 in Consumer Discretionary with a C grade (57/100).